Praveen Ramakrishnan Geethakumari
Overview
Explore the profile of Praveen Ramakrishnan Geethakumari including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
40
Citations
252
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Kometas M, Hoff F, Hyak J, Irizarry-Gatell V, Marinos Velarde A, Jackson C, et al.
Leuk Lymphoma
. 2025 Mar;
:1-9.
PMID: 40053838
Anemia leads to transfusion dependence and decreases quality of life in LR-MDS patients. Our study retrospectively evaluates the efficacy and safety of luspatercept in the real-world treatment of anemia in...
2.
Kharfan-Dabaja M, Mohty R, Easwar N, Johnston P, Iqbal M, Epperla N, et al.
Bone Marrow Transplant
. 2025 Mar;
PMID: 40025178
Older patients with lymphoma are typically underrepresented in clinical trials with chimeric antigen receptor T cell (CAR T) therapy. In this multicenter, observational study we aimed to assess the safety...
3.
Grover N, Annunzio K, Watkins M, Torka P, Karmali R, Anampa-Guzman A, et al.
Blood Cancer J
. 2024 Oct;
14(1):182.
PMID: 39424808
Marginal zone lymphoma (MZL) can have varied presentations and pathologic features, including high Ki-67 expression ( > 20%) as well as increased numbers of large B cells (LC). However, there...
4.
Premnath N, Liu Y, Reves H, Pandey U, Nair R, Anderson J, et al.
JCO Oncol Pract
. 2024 Oct;
:OP2400354.
PMID: 39418621
Purpose: To study the influence of the Affordable Care Act (ACA) policy and its Medicaid expansion on insurance status and survival in patients with HIV with aggressive lymphoma. Methods: We...
5.
Mercadal S, Ahn K, Allbee-Johnson M, Ganguly S, Ramakrishnan Geethakumari P, Hong S, et al.
Haematologica
. 2024 Sep;
110(1):218-221.
PMID: 39234871
No abstract available.
6.
Annunzio K, Grover N, Welkie R, Torka P, Watkins M, Anampa-Guzman A, et al.
Blood Adv
. 2023 Oct;
7(22):6839-6843.
PMID: 37792806
No abstract available.
7.
Jia L, Xing C, Kandathil A, Rosado F, Chen W, Ramakrishnan Geethakumari P
Int J Surg Pathol
. 2023 Jul;
32(3):543-550.
PMID: 37461234
Fibrin-associated large B-cell lymphoma (FA-LBCL) is a rare subtype of Epstein-Barr virus (EBV)-associated lymphoma, recognized as an independent entity per the 5th edition of the WHO classification of hematolymphoid neoplasms....
8.
Mulgaonkar A, Udayakumar D, Yang Y, Harris S, Oz O, Ramakrishnan Geethakumari P, et al.
Front Med (Lausanne)
. 2023 Jul;
10:1199146.
PMID: 37441689
Chimeric antigen receptor (CAR) T-cell therapies have evolved as breakthrough treatment options for the management of hematological malignancies and are also being developed as therapeutics for solid tumors. However, despite...
9.
Hoff F, Goksu S, Premnath N, Patel P, Ikpefan R, Kaur G, et al.
Acta Med Acad
. 2023 Jun;
52(1):30-36.
PMID: 37326395
Objective: Patients diagnosed with hematologic malignancies are at increased risk for severe SARS-CoV-2 infection. We evaluated the serological IgG response following two doses of the SARS-CoV-2 vaccine in patients with...
10.
Epperla N, Zhao Q, Karmali R, Torka P, Shea L, Oh T, et al.
Blood Adv
. 2023 Jun;
7(17):5038-5046.
PMID: 37315169
Given the paucity of data surrounding the prognostic relevance of monoclonal paraprotein (M-protein) in marginal zone lymphoma (MZL), we sought to evaluate the impact of detecting M-protein at diagnosis on...